Molecular targeted therapy towards neurological disorders
Watase, K.; Mizusawa, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 360-364
2012
ISSN/ISBN: 0047-1852 PMID: 23513866 Document Number: 657456
Document emailed within 1 workday
Related Documents
Nakazato, M.; Ohi, T.; Matsukura, S. 1989: Trend in molecular biochemical studies on neurological disorders Nihon Rinsho. Japanese Journal of Clinical Medicine 47(1): 227-238Nonomura, N.; Nakayama, M.; Takayama, H.; Nishimura, K.; Okuyama, A. 2008: Molecular-targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 63-66
Hashimoto, Y.; Naruyama, H.; Ando, R.; Okada, S.; Tozawa, K.; Kohri, K. 2008: Molecular targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 57-61
Wcisło, G. 2008: Molecular underpinnings of the targeted therapy for cancer Acta Poloniae Pharmaceutica 65(6): 633-640
Lea, P.; Ling, M. 2008: New molecular assays for cancer diagnosis and targeted therapy Current Opinion in Molecular Therapeutics 10(3): 251-259
Mizutani, Y.; Nakanishi, H.; Mizuno, M.; Yoshida, J.; Miki, T. 2008: Molecular targeted therapy for renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 54(1): 53-56
Mori, N. 2007: Molecular targeted therapy in adult T-cell leukemia/lymphoma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 1): 709-718
Novik, A.V.; Protsenkol, S.A.; Semenova, A.I.; Latipova, D.K.; A S Zhabina; Akhaeva, Z.Y. 2015: Modern methods of molecular targeted therapy for disseminated melanoma Voprosy Onkologii 61(2): 297-302
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
Shi, Y.; Sun, Y. 2015: Molecular targeted therapy of non-small cell lung cancer in China: the first 10 years Zhonghua Yi Xue Za Zhi 95(8): 564-569
Kuo, H-Yang.; Yeh, K-Huei. 2014: Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review Anticancer Research 34(7): 3695-3699
Gold, S.M.; Voskuhl, R.R. 2006: Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders Current Opinion in Investigational Drugs 7(7): 625-630
Roszkowski, M.; Grajkowska, Wława. 2006: Recent advances in molecular biology of central nervous system embryonal tumors and development of potential molecular targeted therapies Neurologia i Neurochirurgia Polska 40(3): 212-218
Price, R.W.; Yiannoutsos, C.T.; Clifford, D.B.; Zaborski, L.; Tselis, A.; Sidtis, J.J.; Cohen, B.; Hall, C.D.; Erice, A.; Henry, K. 1999: Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team Aids 13(13): 1677-1685
Naito, Y.; Doi, T. 2013: Novel molecular-targeted agents for GIST(Regorafenib etc.) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(1): 15-18
Mano, H. 2009: New molecular targeted EML4-ALK for lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(8): 1268-1270
Kobayashi, T.; Ichikawa, W. 2010: Unique adverse effects of molecular targeted drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1929-1935
Kato, S. 2013: New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(1): 6-9
Tenner, L.L.; O'Neil, B.H. 2014: Colorectal cancer and molecular targeted agents: progress--with caveats Oncology 28(2): 125; 128
Furuta, M.; Yokota, T. 2018: The Combination of Molecular Targeted Agents with Radiotherapy in Head and Neck Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(3): 419-423